1. Home
  2. TEX vs KNSA Comparison

TEX vs KNSA Comparison

Compare TEX & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Terex Corporation

TEX

Terex Corporation

HOLD

Current Price

$60.75

Market Cap

3.0B

Sector

Industrials

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$39.51

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEX
KNSA
Founded
1933
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.6B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
TEX
KNSA
Price
$60.75
$39.51
Analyst Decision
Buy
Strong Buy
Analyst Count
10
6
Target Price
$58.50
$52.33
AVG Volume (30 Days)
1.2M
514.6K
Earning Date
02-05-2026
02-24-2026
Dividend Yield
1.12%
N/A
EPS Growth
N/A
N/A
EPS
2.34
0.47
Revenue
$5,344,000,000.00
$597,973,000.00
Revenue This Year
$7.02
$61.60
Revenue Next Year
$3.97
$29.82
P/E Ratio
$25.87
$82.68
Revenue Growth
4.60
55.68
52 Week Low
$31.53
$17.82
52 Week High
$62.23
$44.42

Technical Indicators

Market Signals
Indicator
TEX
KNSA
Relative Strength Index (RSI) 73.05 39.56
Support Level $56.82 $39.16
Resistance Level $62.23 $43.00
Average True Range (ATR) 1.75 1.75
MACD 0.41 -0.37
Stochastic Oscillator 83.49 26.38

Price Performance

Historical Comparison
TEX
KNSA

About TEX Terex Corporation

Terex is a global manufacturer of aerial work platforms, materials processing equipment, and specialty equipment for the waste, recycling, and utility industries. Its current composition is a result of numerous acquisitions over several decades to focus on a smaller group of light construction and other vocational equipment, having divested a handful of underperforming businesses, particularly in cranes and other lifting equipment. These remaining segments see heavy demand in nonresidential construction (aerial work platforms—40% sales), aggregates/mining (materials processing—30% sales), environmental, waste/recycling and utilities (environmental solutions group—30% sales).

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Share on Social Networks: